111 related articles for article (PubMed ID: 37666280)
1. Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy.
Avagimyan A; Sheibani M; Pogosova N; Mkrtchyan L; Yeranosyan H; Aznauryan A; Sahaakyan K; Fogacci F; Cicero A; Shafie D; Sarrafzadegan N
Int J Cardiol; 2023 Nov; 391():131331. PubMed ID: 37666280
[TBL] [Abstract][Full Text] [Related]
2. Metformin and Dapagliflozin Attenuate Doxorubicin-Induced Acute Cardiotoxicity in Wistar Rats: An Electrocardiographic, Biochemical, and Histopathological Approach.
Satyam SM; Bairy LK; Shetty P; Sainath P; Bharati S; Ahmed AZ; Singh VK; Ashwal AJ
Cardiovasc Toxicol; 2023 Feb; 23(2):107-119. PubMed ID: 36790727
[TBL] [Abstract][Full Text] [Related]
3. THE IMPACT OF TRIMETAZIDINE ON THE ANTHROPOMETRIC PARAMETERS OF DOXORUBICIN-CYCLOPHOSPHAMIDE MODE IN CHEMOTHERAPY-INDUCED HEART ALTERATION.
Avagimyan A; Kakturskiy L
Georgian Med News; 2022 Jan; (322):158-161. PubMed ID: 35134779
[TBL] [Abstract][Full Text] [Related]
4. Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity.
Ulusan S; Gülle K; Peynirci A; Sevimli M; Karaibrahimoglu A; Kuyumcu MS
Anatol J Cardiol; 2023 Jun; 27(6):339-347. PubMed ID: 37257007
[TBL] [Abstract][Full Text] [Related]
5. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients.
Chang WT; Lin YW; Ho CH; Chen ZC; Liu PY; Shih JY
Arch Toxicol; 2021 Feb; 95(2):659-671. PubMed ID: 33211168
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant, lipid lowering, and membrane stabilization effect of sesamol against doxorubicin-induced cardiomyopathy in experimental rats.
Chennuru A; Saleem MT
Biomed Res Int; 2013; 2013():934239. PubMed ID: 24228260
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
Lódi M; Bánhegyi V; Bódi B; Gyöngyösi A; Kovács Á; Árokszállási A; Hamdani N; Fagyas M; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2020 Dec; 18(1):470. PubMed ID: 33298102
[TBL] [Abstract][Full Text] [Related]
9. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium.
Cappetta D; De Angelis A; Ciuffreda LP; Coppini R; Cozzolino A; Miccichè A; Dell'Aversana C; D'Amario D; Cianflone E; Scavone C; Santini L; Palandri C; Naviglio S; Crea F; Rota M; Altucci L; Rossi F; Capuano A; Urbanek K; Berrino L
Pharmacol Res; 2020 Jul; 157():104781. PubMed ID: 32360273
[TBL] [Abstract][Full Text] [Related]
11. Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats.
Haybar H; Goudarzi M; Mehrzadi S; Aminzadeh A; Khodayar MJ; Kalantar M; Fatemi I
Biomed Pharmacother; 2019 Jan; 109():530-535. PubMed ID: 30551518
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
[TBL] [Abstract][Full Text] [Related]
13. β-caryophyllene, a dietary phytocannabinoid attenuates oxidative stress, inflammation, apoptosis and prevents structural alterations of the myocardium against doxorubicin-induced acute cardiotoxicity in rats: An in vitro and in vivo study.
Al-Taee H; Azimullah S; Meeran MFN; Alaraj Almheiri MK; Al Jasmi RA; Tariq S; Ab Khan M; Adeghate E; Ojha S
Eur J Pharmacol; 2019 Sep; 858():172467. PubMed ID: 31216443
[TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation.
Hsieh PL; Chu PM; Cheng HC; Huang YT; Chou WC; Tsai KL; Chan SH
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077544
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17β-estradiol in female tumor-bearing spontaneously hypertensive rats.
Pokrzywinski KL; Biel TG; Rosen ET; Bonanno JL; Aryal B; Mascia F; Moshkelani D; Mog S; Rao VA
Biol Sex Differ; 2018 Jun; 9(1):25. PubMed ID: 29907135
[TBL] [Abstract][Full Text] [Related]
16. Cardio-protective effect of dapagliflozin against doxorubicin induced cardiomyopathy in rats.
Belen E; Canbolat IP; Yigittürk G; Cetinarslan Ö; Akdeniz CS; Karaca M; Sönmez M; Erbas O
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4403-4408. PubMed ID: 35776041
[TBL] [Abstract][Full Text] [Related]
17. Modeling Doxorubicin-Induced Cardiomyopathy With Fibrotic Myocardial Damage in Wistar Rats.
Podyacheva E; Shmakova T; Kushnareva E; Onopchenko A; Martynov M; Andreeva D; Toropov R; Cheburkin Y; Levchuk K; Goldaeva A; Toropova Y
Cardiol Res; 2022 Dec; 13(6):339-356. PubMed ID: 36660062
[TBL] [Abstract][Full Text] [Related]
18. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
[TBL] [Abstract][Full Text] [Related]
19. Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model.
Kondru SK; Potnuri AG; Allakonda L; Konduri P
Mol Cell Biochem; 2018 Apr; 441(1-2):77-88. PubMed ID: 28887671
[TBL] [Abstract][Full Text] [Related]
20. Sheng-mai-san reduces adriamycin-induced cardiomyopathy in rats.
You JS; Huang HF; Chang YL; Lee YS
Am J Chin Med; 2006; 34(2):295-305. PubMed ID: 16552840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
